In addition, MAPKs contribute to a decrease in lymphocyte counts, including lymphocyte necrosis and NK and T-cell exhaustion promoted by IL-6, which is commonly observed in COVID-19 patients [254]. This evidence concerns the gene IL6 and COVID-19.